Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 16/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 10/20 | 0.38 |
| ▸ | ADCY5 | O95622 | 2/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19667277 | 0.83 | PRMT5 (0.37) | PRMT5WDR77ADCY5GPR119ACACB | |
| SCHEMBL19667418 | 0.77 | ADCY5 (0.39) | PRMT5WDR77ADCY5ACACB | |
| SCHEMBL19667419 | 0.76 | ADCY5 (0.40) | PRMT5WDR77ADCY5 | |
| SCHEMBL19667421 | 0.76 | PRMT5 (0.42) | PRMT5WDR77 | |
| SCHEMBL19684699 | 0.75 | PRMT5 (0.39) | PRMT5WDR77 | |
| SCHEMBL19679203 | 0.75 | PRMT5 (0.38) | PRMT5WDR77 | |
| SCHEMBL13170758 | 0.74 | PRMT5 (0.36) | PRMT5WDR77ADCY5 | |
| SCHEMBL19667556 | 0.73 | PRMT5 (0.35) | PRMT5WDR77 | |
| SCHEMBL10186279 | 0.73 | PRMT5 (0.38) | PRMT5WDR77 | |
| SCHEMBL19667549 | 0.72 | GPR119 (0.37) | PRMT5WDR77GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10709709-B2 | Substituted carbonucleoside derivatives useful as anticancer agents | PFIZER INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-20190111060-A1 | SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER INC. (US) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10709709-B2 | Substituted carbonucleoside derivatives useful as anticancer agents | DUT, NCL, TYMP | PRMT5 1945/4885WDR77 1906/4885ADCY5 3640/4885 |
| US-20190111060-A1 | SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS | DUT, NCL, TYMP | PRMT5 1945/4885WDR77 1906/4885ADCY5 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.